Human SARS-CoV-2 Spike Protein Total Antibody ELISA Kit | abx365085
- Usually shipped in 5 working days
- 96 Tests
Human SARS-CoV-2 Spike Protein Total Antibody ELISA Kit. Cat# abx365085. Supplier: abbexa.
Human Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2/COVID-19) Spike Protein Total Antibody ELISA Kit is an ELISA kit for qualitative detection of SARS-CoV-2/COVID-19 Spike Protein total antibodies in Human serum and plasma.
The SARS-CoV-2 Spike Protein (S protein) is a viral protein that allows the entry of SARS-CoV-2 into human cells. The protein forms trimers on the viral capsid and binds to human Angiotensin Converting Enzyme 2 (ACE2) located on the cell surface. The protein has a cleavage site between the S1 and S2 subunits that is targeted by the human enzyme Furin, and it may also cause the development of a syncytium (cell fusion). Antibodies to S protein can prevent viral entry as well as target the virus for further immune action.
|SARS-CoV-2 Spike Protein Total Antibody
|Optimal dilutions/concentrations should be determined by the end user.
|Shipped at 4 °C. Upon receipt, store the kit according to the storage instruction in the kit's manual.
|The validity for this kit is 6 months.
|The stability of the kit is determined by the rate of activity loss. The loss rate is less than 5% within the expiration date under appropriate storage conditions. To minimize performance fluctuations, operation procedures and lab conditions should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same user throughout.
|Serum, plasma and other biological fluids.
|Shipped within 5-12 working days.
|This product is for research use only.
The range and sensitivity is subject to change. Please contact us for the latest product information. For accurate results, sample concentrations must be diluted to mid-range of the kit. If you require a specific range, please contact us in advance or write your request in your order comments.
Please note that our ELISA and CLIA kits are optimised for detection of native samples, rather than recombinant proteins. We are unable to guarantee detection of recombinant proteins, as they may have different sequences or tertiary structures to the native protein.